Kim PH, Cha EK, Sfakianos JP, Iyer G, Zabor EC, et al. Genomic Predictors of Survival in Patients with High-grade Urothelial Carcinoma of the Bladder. European urology. Feb 2015;67(2):198-201.
Begg CB, Seshan VE, Zabor EC, et al. Genomic investigation of etiologic heterogeneity: methodologic challenges. BMC medical research methodology. 2014;14:138.
Begg CB, Zabor EC, Bernstein JL, Bernstein L, Press MF, Seshan VE. A conceptual and methodological framework for investigating etiologic heterogeneity. Statistics in medicine. Dec 20 2013;32(29):5039-5052.
Hakimi AA, Furberg H, Zabor EC, et al. An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. Journal of the National Cancer Institute. Dec 18 2013;105(24):1862-1870.
Zabor EC, Gonen M, Chapman PB, Panageas KS. Dynamic prognostication using conditional survival estimates. Cancer. Oct 15 2013;119(20):3589-3592.
Iyer G, Al-Ahmadie H, Schultz N, …, Zabor EC, et al. Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Sep 1 2013;31(25):3133-3140.
Zabor EC, Li Y, Thornton LM, et al. Initial reactions to tobacco use and risk of future regular use. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. Feb 2013;15(2):509-517.
Begg CB, Zabor EC. Detecting and exploiting etiologic heterogeneity in epidemiologic studies. American journal of epidemiology. Sep 15 2012;176(6):512-518.